26
Mar
2018
Mt. Everest: It’s Time
Six months of hard training is in the bank. Tomorrow morning, I will lug a pair of 120-liter gear bags to the airport and get on the plane for Kathmandu. Destination: Mt. Everest, 29,029 feet/8,848 meters. The summit of the highest mountain in the world. No matter what happens, three things are certain: I’ve given it everything I’ve got to prepare...Read More 
Share:
23
Mar
2018
The Data Wake-Up, AbbVie’s $5.8B Whiff, and a Regeneron-Alnylam Alliance
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
21
Mar
2018
TCR2 Therapeutics Grabs $125M to Take TCR Therapies, Sans HLA Screens, To the Clinic
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
Mar
2018
Shkreli Goes to Jail, Holmes Gets Fined, & Gilead CSO Exits With Barely a Peep
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
14
Mar
2018
From Rock DJ to Scientist to Entrepreneur: Michael Gilman on The Long Run Podcast
Today’s guest on The Long Run podcast is Michael Gilman. He’s the CEO of a pair of Boston-area biotech startups. One is Arrakis Therapeutics, a company attempting to make small molecule drugs against RNA targets. The other is Obsidian Therapeutics, a company seeking to take the next step in CAR-T immunotherapy, by carefully controlling dosing to avoid some of the...Read More
Share:
12
Mar
2018
Photo Gallery: The Boston Cancer Summit
What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...Read More
Share:
12
Mar
2018
Photo Gallery: The Seattle Cancer Summit
What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...Read More
Share:
8
Mar
2018
What’s Better Than Curing Cancer? Preventing It!
You don’t have to be an oncologist to know that fighting cancer is tough. Nearly 1.7 million Americans will be diagnosed with cancer this year, and about 600,000 will die from the disease. But here’s some good news: overall U.S. cancer deaths have been in a steep decline for over 25 years. Much of this reduction is tied to a...Read More
Share:
5
Mar
2018
Getting to Precision Medicine for I-O Combinations – It’s Even More Complicated
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
2
Mar
2018
Celgene Drops the Ball and a Flurry of VC Deals: Frontpoints
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
28
Feb
2018
Matching Up Technology & People: Bruce Booth on The Long Run Podcast
Bruce Booth is the latest guest on The Long Run podcast. Booth, a partner with Atlas Venture, has made a name for himself the past few years as the author of the LifeSciVC blog. He writes about industry investment trends, the occasional news item from Atlas portfolio companies, and occasionally shines a light into the dark little corners of the...Read More
Share:
26
Feb
2018
The Henri A. Termeer Tribute: An Uplifting Idea for a Tumultuous Time
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
23
Feb
2018
Gilead’s Latest CAR-T Domino, Takeda’s Deal Spree, & Merck’s Oncolytics Bet
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
20
Feb
2018
Through the Looking Glass with PheWAS
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
16
Feb
2018
All-Star Lineup for Boston Cancer Summit, March 7: Novartis, J&J, Third Rock, Atlas
Timmerman Report is bringing together major East Coast cancer R&D players for an intimate half-day event on March 7: the Boston Cancer Summit. Join an all-star gathering of pharma executives, hot startups, and VCs making things happen in the treatment and diagnosis of cancer. Tickets are sold out. The conference will be at Sanofi Genzyme’s flagship building in the heart of Kendall Square....Read More
Share:
15
Feb
2018
Mingle in Seattle with Genentech, Celgene, OrbiMed, 5AM & More, March 5
Exclusive Event, Powerhouse Lineup: Seattle Cancer Summit Seattle biotech events don’t get any better than this. Timmerman Report is bringing together major West Coast players for an intimate half-day event on March 5: the Seattle Cancer Summit. Tickets are limited and going fast. And all proceeds go to the Fred Hutchinson Cancer Research Center, as part of my Everest Climb to Fight...Read More
Share:
14
Feb
2018
Building a Cancer R&D Engine To Last: David Schenkein on The Long Run
Today’s guest on The Long Run podcast is David Schenkein. He’s the CEO of Cambridge, Mass.-based Agios Pharmaceuticals. Agios was founded a decade ago on the then-provocative idea of fighting cancer via new understanding of metabolic pathways that get hijacked by cancer cells. The company has grown up quite a bit since. It went from concept to new chemical entities...Read More
Share:
9
Feb
2018
BMS Makes Case for TMB, Express Scripts Sees Drug Price Slowdown, & Theravance Pockets $100M
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
5
Feb
2018
The Caveman’s Guide to Productivity
One TR subscriber already knew about some of my quirks: he and I rode in a van together for 26 hours straight to do the 200-mile Ragnar Reach the Beach Relay in New Hampshire. But when I published last month’s column detailing my Everest training, he wanted to know more. “I study performance pretty carefully, so all these kinds of questions fascinate...Read More
Share:
2
Feb
2018
Amazon Sizes Up Healthcare Beast, Vertex Raises the Bar in CF, Moderna Hauls in Another $500M
This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.
Share:
